This study is in progress, not accepting new patients

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

a study on Kidney Cancer Kidney Neoplasm

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Los Angeles, California and other locations
Dates
study started
completion around

Description

Summary

The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection

Keywords

Renal Cancer, ablation, quality of Life (QOL), kidney, registry, Ablation of Renal Masses Outcomes Registry (ARMOR), 13-116, Kidney Neoplasms, renal mass ablation candidates

Eligibility

You can join if…

Open to people ages 18 years and up

Retrospective enrollment:

  • Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal mass.

Prospective enrollment:

  • Patients scheduled to undergo, rather than having undergone, percutaneous, open or laparoscopic energy ablation of a renal mass.

You CAN'T join if...

  • Patients not having undergone, or considered candidates for percutaneous, open or laparoscopic energy ablation of a renal mass
  • Non-English speaking patients
  • Patients under the age of 18.

Locations

  • University of California, Los Angeles
    Los Angeles California 90095 United States
  • Md Anderson Cancer Center
    Houston Texas 77030 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Memorial Sloan Kettering Cancer Center
Links
Memorial Sloan Kettering Cancer Center
ID
NCT01888198
Study Type
Observational [Patient Registry]
Participants
Expecting 294 study participants
Last Updated